Jamwolf, appreciate your comments. However the ONLY reason the shareprice has been so low over the last few years is because of lack of funds. We have seen all the US based RNAi companies go up in the 1000s of percents, despite many of them having inferior technology. Alnylam is a $6.5b company. They have nothing close to commercialisation. ddRNAi will be just as validated THIS YEAR, and BLT own all the core patents. Not only that, we are not dealing in the orphan diseases category.
The brakes are off.
- Forums
- ASX - By Stock
- cashed up, ready to make medical history
Jamwolf, appreciate your comments. However the ONLY reason the...
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online